What are the latest trends in CEE market access demonstrating value? Are they ensuring patients access to lifesaving and innovative health technologies? Is there a place to managed entry agreements and what new approaches are applied to pricing solutions and reimbursement programs?

Participants of this interactive Forum will discuss vision towards the market access environment, strategic plan, and how to optimise access and value of innovative medicines in CEE. Interactive participation by the audience is anticipated.

ISPOR CEE Consortium